Neuronetics, Inc. (STIM)
NASDAQ: STIM · IEX Real-Time Price · USD
1.750
0.00 (0.00%)
At close: Jul 2, 2024, 4:00 PM
1.700
-0.050 (-2.86%)
After-hours: Jul 2, 2024, 7:30 PM EDT
Neuronetics Market Cap
Neuronetics has a market cap or net worth of $52.50 million as of July 2, 2024. Its market cap has decreased by -11.92% in one year.
Market Cap
52.50M
Enterprise Value
64.30M
1-Year Change
-11.92%
Ranking
Category
Stock Price
$1.75
Market Cap Chart
Since June 28, 2018, Neuronetics's market cap has decreased from $451.30M to $52.50M, a decrease of -88.37%. That is a compound annual growth rate of -30.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 52.50M | -37.43% |
| Dec 29, 2023 | 83.90M | -55.13% |
| Dec 30, 2022 | 187.00M | 59.01% |
| Dec 31, 2021 | 117.60M | -44.21% |
| Dec 31, 2020 | 210.80M | 151.85% |
| Dec 31, 2019 | 83.70M | -75.40% |
| Dec 31, 2018 | 340.20M | -24.62% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ARCA biopharma | 55.13M |
| Cidara Therapeutics | 54.92M |
| Passage Bio | 54.55M |
| Allurion Technologies | 53.72M |
| Mural Oncology | 52.63M |
| Bright Green | 52.39M |
| Reneo Pharmaceuticals | 51.80M |
| VolitionRx | 51.33M |